Cargando…
The p97 Inhibitor UPCDC-30245 Blocks Endo-Lysosomal Degradation
The diverse modes of action of small molecule inhibitors provide versatile tools to investigate basic biology and develop therapeutics. However, it remains a challenging task to evaluate their exact mechanisms of action. We identified two classes of inhibitors for the p97 ATPase: ATP competitive and...
Autores principales: | Wang, Feng, Li, Shan, Cheng, Kai-Wen, Rosencrans, William M., Chou, Tsui-Fen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880557/ https://www.ncbi.nlm.nih.gov/pubmed/35215314 http://dx.doi.org/10.3390/ph15020204 |
Ejemplares similares
-
Optimization of Phenyl Indole Inhibitors of the AAA+
ATPase p97
por: LaPorte, Matthew G., et al.
Publicado: (2018) -
Impacts of p97 on Proteome Changes in Human Cells during Coronaviral Replication
por: Cheng, Kai-Wen, et al.
Publicado: (2021) -
IBMPFD Disease-Causing Mutant VCP/p97 Proteins Are Targets of Autophagic-Lysosomal Degradation
por: Bayraktar, Oznur, et al.
Publicado: (2016) -
NMS-873 Leads to Dysfunctional Glycometabolism in A p97-Independent Manner in HCT116 Colon Cancer Cells
por: Li, Shan, et al.
Publicado: (2022) -
Correction: IBMPFD Disease-Causing Mutant VCP/p97 Proteins Are Targets of Autophagic-Lysosomal Degradation
Publicado: (2016)